Member Info for WeTookPelham

Maybe it's just me, and I'm not looking correctly but Scancell's Linkedin presence (as in the compnay itself) seems have been removed? Although admittedly I don't think they were too bothered with to begin with, because i remember there being 2 entries:
- Scancell Holdings PLC
- Scancell Ltd

Click on the "Scancell Holdings/Scancell Ltd" links in the profiles or do a search and you'll see what i mean:
https://www.linkedin.com/in/cliffholloway/
https://www.linkedin.com/in/lindy-durrant-817883ab/

Now maybe it's nothing of consequence, or maybe....it could be a company re-naming/re-branding! ;) (or maybe just finally tidying it up!)

If you remember Scancell were recruiting 1 x research technician and 3 x research scientists in specialist areas, well they are no longer recruiting so I'm guessing they have a list of suitable candidates to interview or interviews are taking/have taken place?
https://jobs.newscientist.com/en-gb/job/1401720181/research-technician/
https://jobs.newscientist.com/en-gb/job/1401720180/research-scientist-3-positions-available-/
https://jobs.newscientist.com/en-gb/employer/200002866/scancell-ltd/

That report is a great find Cossie!
Excuse my ignorance though, but does that report reads a little bit like a Trinity Delta report? I don't quite understand what Turner Pope position is, are they basically a Hargreaves Lansdowne for high very net worth individuals then? And they are providing a report on an potentially investment target (i.e. Scancell) for their clients? Or they an investment fund too?
Either way I'm a little surpised that report is avaible to all.

https://science.thewire.in/health/covid-coronavirus-mink-vaccine-development/

"The virus produced by the mink mutation, on the other hand, seems impervious to antibodies produced in response to the dominant strain of the virus. What makes this mutation so much more troubling than previous mutations is not that the mutation increases how quickly the virus will spread, nor that it increases the severity of resultant disease. It’s the fact that the immune system cannot transfer knowledge about one form of the virus in fighting the other form. From the perspective of your immune system, they are two different viruses altogether.

In other words, if you have survived COVID-19, your immune system remains largely unequipped to battle the mink strain. Once pharmaceutical companies finish their months-long race to devise an effective COVID vaccine, the vaccine would likely provide little protection against the emerging strain. The virus has mutated into what could eventually be thought of as COVID 2.0 if the Danes fail to contain its spread."

Apologies if already mentioned... Some big trades today then it seems?

Date
Time
Price
Currency
Volume
Trade Value
Trade type
Trade flag
MIC
18.11.20
15:23:40
12.00
GBX
170,000
20,400.00
Off-Book
LRGS
AIMX

Is it just me that's a little surprised by the tick down?

Sounds like someone has hedged with a short IMO ;)

Please post updates if possible!

Yep, serious appointments it seems.

https://www.linkedin.com/in/gillies-o-bryan-tear-4240776?originalSubdomain=uk

They can comment before the AGM though ;)

https://twitter.com/trinity_delta/status/1328649913551495168

Found some details RE the Innovate funding, not sure if this has bee posted before?
(p.s. £2.5million? More than i thought but still paltry IMO)

https://gtr.ukri.org/projects?ref=73437

https://gtr.ukri.org/search/project?term=scancell&selectedFacets=&fields=pub.t,per.pro.abs,pro.t,per.org.n,per.fnsn,per.sn,per.pro.t,pub.a,per.on,pro.gr,org.n,per.fn,pro.a&type=&fetchSize=100&page=1&selectedSortableField=pro.ed&selectedSortOrder=DESC

Still bemused why it took so long for Scancell/Nottingham to receive the Innovative funds in the first place, and the fact it was only a paltry £2m... relatively speaking. Considering the huge amounts of money they've thrown about/wasted on the pandemic.
Purely IMO they hedged their bets on the Oxford too much.

Is this another/new/third purchase by Vulpes? It's not showing on Investegate?

Question for the science types, seeing the positive data for the 2 x mRNA vaccines, do we think Oxford/AstraZeneca's can get close to those kind of results? And what kind of results could we expect from Covidity/other DNA vaccines? More closely aligned to the mRNA vaccine types? And can SCIB1's results provide a useful insight into what we could expect results wise?

The reason I ask is the UK government who have obviously backed the Oxford (Adenovirus) one fully, may now be thinking maybe they backed the wrong "type" of horse? Which (hopefully) may mean more focus by the UK government on mRNA and DNA vaccines? I.e. Covidity?
https://www.nytimes.com/interactive/2020/05/20/science/coronavirus-vaccine-development.html

Incidentally was not aware that the UK government did not order any of the Moderna vaccine, only the Pzifer one which appears to be much more of logistical pain in the backside.

Will start a new thread...

https://www.bloomberg.com/news/articles/2020-11-16/moderna-vaccine-is-found-highly-effective-at-preventing-covid-19

Appears to be less demanding than Pfizers RE storage but still not straightfoward. Some side effects too:

@c7 - https://www.bbc.co.uk/news/health-54902908

Interesting how the Moderna news isn't causing the same kind of effect as last week's Pfizer/BioNtech vaccine news?
Makes me wonder more about tomorrow?

"Stocks Making: Hammer Candlestick on 2020-11-12
The Hammer is a bullish reversal pattern that forms after a decline. In addition to a potential trend reversal, hammers can mark bottoms or support levels. After a decline, hammers signal a bullish revival."

SCLP 11.38 -0.22 2,436,328 0.96

(Taken from swingtradebot)

From my limited knowledge I would say that BioNTech and Scancell have a great synergy and not just because of the exisiting relationships/work/research/Redmile connection, but pipeline too, so surely if any big pharma is going to licence/part buy/wholly buy Scancell, BioNTech must be at the front of that queue by a long way? Thoughts?

And they are going to be come even more cash rich now that their vaccine seems to be the one leading the pack and the one everyone is clamouring for atm.
Market cap $25b and rising fast.
https://finance.yahoo.com/quote/BNTX/key-statistics?p=BNTX